Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80.

Article  Google Scholar 

Mondello S, Hayes RL. Biomarkers. Handbook Clin Neurol. 2015;127:245–65.

Article  Google Scholar 

Pasi M, Cordonnier C. Clinical relevance of cerebral small vessel diseases. Stroke. 2020;51(1):47–53. https://doi.org/10.1161/strokeaha.119.024148.

Article  PubMed  Google Scholar 

Pantoni L, Gorelick P. Advances in vascular cognitive impairment 2010. Stroke. 2011;42:291–3.

Article  PubMed  Google Scholar 

Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CL-H. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88(8):669–74.

Article  PubMed  Google Scholar 

Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20.

Article  CAS  PubMed  Google Scholar 

Rao P, Benito E, Fischer A. MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci. 2013;6:39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prabhakar P, Chandra SR, Christopher R. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease. Age Ageing. 2017;46:861–4.

Article  PubMed  Google Scholar 

Farag S, Kenawy FF, Shokri HM, Zakaria M, Aref H, Fahmi N, et al. The clinical characteristics of patients with pre-existing leukoaraiosis compared to those without leukoaraiosis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2021;30(9): 105956.

Article  PubMed  Google Scholar 

Rahman TT, El Gaafary MM. Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 2009;9(1):54–61.

Article  PubMed  Google Scholar 

Wolf SL, Catlin PA, Gage K, Gurucharri K, Robertson R, Stephen K. Establishing the reliability and validity of measurements of walking time using the Emory functional ambulation profile. Phys Ther. 1999;79(12):1122–33.

Article  CAS  PubMed  Google Scholar 

Berg K. Measuring balance in the elderly: preliminary development of an instrument. Physiother Can. 1989;41(6):304–11.

Article  Google Scholar 

Abdel-Khalek AM. Internal consistency of an Arabic adaptation of the Beck Depression Inventory in four Arab countries. Psychol Rep. 1998;82(1):264–6.

Article  CAS  Google Scholar 

Hashim H, Avery K, et al. The Arabic ICIQ-UI SF: An alternative language version of the English ICIQ-UI SF. Neurourol Urodyn. 2006;25(3):277–82.

Article  CAS  Google Scholar 

Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683–9.

Article  CAS  PubMed  Google Scholar 

Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–34.

Article  PubMed Central  Google Scholar 

Pasquier F, Leys D, Weerts JG, et al. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1997;36(5):268–72.

Article  Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.

Article  CAS  PubMed  Google Scholar 

Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis. 2003;16(3):280–5.

Article  PubMed  Google Scholar 

Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–96.

Article  PubMed  Google Scholar 

Szcześniak D, Rymaszewska J, Zimny A, et al. Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland. Geroscience. 2021;43(1):279–95.

Article  PubMed  Google Scholar 

Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CL. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88:669–74.

Article  Google Scholar 

Wang Z, Chen Q, Chen J, Yang N, Zheng K. Risk factors of cerebral small vessel disease: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(51):e28229.

Article  CAS  PubMed  Google Scholar 

Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. Cerebral small vessel disease: a review. Adv Clin Exp Med. 2021;30(3):349–56.

Article  PubMed  Google Scholar 

Pinter D, Ritchie SJ, Gattringer T, Bastin ME, del Hernández M, Corley J, et al. Predictors of gait speed and its change over three years in community-dwelling older people. Aging. 2018;10(1):144–53.

Article  PubMed  PubMed Central  Google Scholar 

Staals J, Booth T, Morris Z, Bastin ME, Gow AJ, Corley J, et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging. 2015;36(10):2806–11.

Article  PubMed  PubMed Central  Google Scholar 

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking MIRNA-1-2. Cell. 2007;129(2):303–17.

Article  CAS  PubMed  Google Scholar 

Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle. 2007;6(17):2127–32.

Article  CAS  PubMed  Google Scholar 

Cheng CY, Chen SP, Liao YC, Fuh JL, Wang YF, Wang SJ. Elevated circulating endothelial-specific microRNAs in migraine patients: a pilot study. Cephalalgia. 2018;38(9):1585–91.

Article  PubMed  Google Scholar 

Soliman R, Mousa NO, Rashed HR, Moustafa RR, Hamdi N, Osman A, et al. Assessment of diagnostic potential of some circulating micrornas in amyotrophic lateral sclerosis patients, an Egyptian study. Clin Neurol Neurosurg. 2021;208: 106883.

Article  PubMed  Google Scholar 

Huang S, Zhao J, Huang D, Zhuo L, Liao S, Jiang Z. Serum Mir-132 is a risk marker of post-stroke cognitive impairment. Neurosci Lett. 2016;615:102–6.

Article  CAS  PubMed  Google Scholar 

Ragusa M, Bosco P, Tamburello L, et al. miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications. Front Cell Neurosci. 2016;10:51.

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Ji B, Cheng B, Chen J, Bai B. Neuroprotection of microRNA in neurological disorders (review). Biomed Rep. 2014;2(5):611–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral micrornas that are upstream to neuroprotective signaling pathways. J Neurochem. 2010;113(6):1685–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lusardi TA, Farr CD, Faulkner CL, Pignataro G, Yang T, Lan J, et al. Ischemic preconditioning regulates expression of micrornas and a predicted target, MECP2, in mouse cortex. J Cereb Blood Flow Metab. 2009;30(4):744–56.

Article  PubMed  PubMed Central  Google Scholar 

Smith EE, Markus HS. New treatment approaches to modify the course of cerebral small vessel diseases. Stroke. 2020;51(1):38–46.

Article  PubMed  Google Scholar